Çocukluk çağında inme

Damar kaynaklı olan ve 24 saatten uzun süren fokal nörolojik kayıp inme olarak tanımlanır. Çocuklarda inme pek çok nedene bağlı gelişebilir. İnme, çocuklarda kronik hastalık halinin ve ölümün önemli nedenlerinden biridir. Son dönemde yaygın olarak kullanılmaya başlanan girişimsel olmayan radyolojik yöntemler sayesinde çocuklarda inme giderek artan sıklıkta fark edilmeye başlanmıştır. (Türk Ped Arş 2007; 42: 6-12)

Childhood stroke

A focal neurological deficit lasting more than 24 hours resulting from a vascular pathology is defined as stroke. A large number of conditions predispose to stroke in children. Stroke results in significant mortality and long-term morbidity in children. Pediatric stroke is increasingly recognized because of the widespread use of noninvasive radiological studies. (Turk Arch Ped 2007; 42: 6-12)

PDF

___

Ball WS. Cerebrovascular occlusive disease in childhood. Neuroimaging Clin N Am 1994; 4; 393-421.
Koelfen W, Wentz U, Freund M, Schultze C. Magnetic reso nance angiography in 140 neuropediatric patients. Pediatr Neurol 1995; 12: 31-8.
Butler IJ. Cerebrovascular disorders of childhood. J Child Neurol 1993; 8: 197-200.
Broderick J, Talbot T, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising im portance of intracerebral hemorrhage. J Child Neurol 1993; 8:250-5.
Lynch JK. Cerebrovascular disorders in children. Curr Neurol Neurosci Rep 2004; 4: 129-38.
Lynch JK, Han CJ. Pediatric stroke: what do we know and what do we need to know? Semin Neurol 2005; 25: 410-23.
Gulati S, Kalra V. Stroke in children. Indian J Pediatr 2003; 70: 639-48.
Barron TF, Gusnard DA, Zimmerman RA, Clancy RR. Cerebral venous thrombosis in neonates and children. Pediatr Neurol 1992; 8: 112-6.
deVeber GA, Adams M, Andrew M. Canadian Pediatric ischemic stroke registry (Abstract). Can J Neurol Sci 1995; 22: S24.
Roach ES. Etiology of stroke in children. Semin Pediatr Neurol 2000; 7: 244-50.
Strater R, Vielhaber H, Kassenbohmer R, von Kries R, Gobel U, Nowak-Gottl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin: a prospective ESPED survey. Eur J Pediatr 1999; 158: S122-5.
DeVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembo-lism. Arch Neurol 1998; 55: 1539-43.
DeVeber G. Stroke and the child's brain: an overview of epi demiology, syndromes and risk factors. Curr Opin Neurol 2002; 15: 133-8.
DeVeber GA, MacGregor D, Curtis R, Mayank S. Neurolo gic outcome in survivors of childhood arterial ischaemic stroke and sinovenous thrombosis. J Child Neurol 2000; 15:316-24.
Bonduel M, Sciuccati G, Hepner M, Torres AF, Pieroni G, Frontroth JP. Prothrombotic disorders in children with arte rial ischemic stroke and sinovenous thrombosis. Arch Ne urol 1999; 56: 967-71.
Golomb MR, MacGregor DL, Domi T, et al. Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol 2001; 50: 163-8.
Kittner SJ, Adams RJ. Stroke in children and young adults. Curr Opin Neurol 1996; 9: 53-6.
Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Du mas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995: 48: 1343-8.
Kirkham FJ, Prengler M, Hewes DK, Ganesan V. Risk factors for arterial ischemic stroke in children. J Child Neurol 2000; 15:299-307.
Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM. Presentation, clinical course, and outcome of childhood stroke. Pediatr Ne urol 1991; 7: 333-41.
Manco-Johnson MJ; Nuss R, Key N, et al. Lupus anticoagu lant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996; 128: 319-23.
Montes de Oca MA, Babron MC, Bletry O, et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 1991; 66: 713-8.
Ravelli A, Martini A, Burgio GR. Antiphospholipid antibodies in paediatrics. Eur J Pediatr 1994; 153: 472-9.
Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326: 605-10.
Askalan R, Laughlin S, Mayank S, et al. Chickenpox and stro ke in childhood: a study of frequency and causation. Stroke 2001; 32: 1257-62.
Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the Na tional Institute of Neurological Disorders and Stroke Works hop on Perinatal and Childhood Stroke. Pediatrics 2002; 109: 116-23.
deVeber G, Andrew M. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-23.
Deschiens MA, Conard J, Horellou MH, et al. Coagulation stu dies, factor V Leiden, and anticardiolipin antibodies in 40 ca ses of cerebral venous thrombosis. Stroke 1996; 27: 1724-30.
Zuber M, Toulon P, Marnet L, Mas JL. Factor V Leiden muta tion in cerebral venous thrombosis. Stroke 1996; 27: 1721-23.
Von Scheven E, Athreya BH, Rose CD, Goldsmith DP, Mor ton L. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996; 129: 339-45.
Menovsky T, van Overbeeke JJ. Cerebral arteriovenous mal formations in childhood: state of the art with special referen ce to treatment. Eur J Pediatr 1997; 156: 741 -6.
Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G.Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54: 371-8.
Zimmerman RA, Haselgrove JC, Wang Z, et al. Advances in pediatric neuroimaging. Brain Dev 1998; 20: 275-89.
Gadian DG, Calamante F, Kirkham FJ, et al. Diffusion and perfusion magnetic resonance imaging in childhood stroke. J Child Neurol 2000; 15: 279 -83.
Leys D, Lucas C, Gobert M, Deklunder G, Pruvo JP. Cervical artery dissections. Eur Neurol 1997; 37: 3-12.
Ganesan V, Savvy L, Chong WK, Kirkham FJ. Conventional cerebral angiography in children with ischemic stroke. Pedi atr Neurol 1999; 20: 38-42.
deVeber G, Chan A, Monagle P, et al. Anticoagulation the rapy in pediatric patients with sinovenous thrombosis: a co hort study. Neurology 1998; 51: 1622-88.
deVeber GA, Chan A, Monagle P, et al. Anticoagulation the rapy in pediatric patients with sinovenous thrombosis: a co hort study. Arch Neurol 1998; 55: 1533-7.
de Veber G, Roach ES, Riela AR, et al. Stroke in children: re cognition, treatment, and future directions. Semin Ped Ne urol 2000; 7: 309.
deVeber G, Andrew M, Adams M, et al. Treatment of pediat ric sinovenous thrombosis with low molecular weight hepa rin (Abstract). Ann Neurol 1995; 38: 532.
Dix D, Andrew M, Marzinotto V, et al. The use of low mole cular weight heparin in pediatric patients: a prospective co hort study. J Pediatr 2000; 136: 439-45.
Hirsh J. Heparin. N Engl J Med 1991; 324: 1565-74.
Andrew M, Marzinotto V, Broker LA, et al. Oral anticoagula tion therapy in pediatric patients: a compherensive review of the literature. Thromb Haemost 1996; 76: 132.
Higashida RT, Helmer E, Halbach VV, Hieshima GB. Direct thrombolytic therapy for superior sagittal sinus thrombosis. Am J Neuroradiol 1989; 10: S4-6.
Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360-6.
Adams RJ. Lessons from the stroke prevention trial in sickle cell anemia (STOP) study. J Child Neurol 2000; 15: 344-9.
Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: S 645-87.